International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita

Epidermolysis bullosa acquisita (EBA) is a complex autoimmune bullous disease disease with variable clinical presentations and multiple possible diagnostic tests, making an international consensus on the diagnosis of EBA essential.

[1]  Y. Kajihara.  Exfoliative esophagitis. , 2018, European journal of internal medicine.

[2]  R. Ludwig,et al.  Clinical features and diagnosis of epidermolysis bullosa acquisita , 2017, Expert review of clinical immunology.

[3]  M. Jonkman,et al.  Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid. , 2016, JAMA dermatology.

[4]  A. Hovnanian,et al.  Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA). , 2016, Journal of the American Academy of Dermatology.

[5]  T. Hashimoto,et al.  Type VII collagen is the major autoantigen for sublamina densa-type linear IgA bullous dermatosis. , 2015, The Journal of investigative dermatology.

[6]  J. Schmitt,et al.  Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME) , 2014, The British journal of dermatology.

[7]  A. España,et al.  Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain , 2014, The British journal of dermatology.

[8]  D. Zillikens,et al.  Anti-p200 pemphigoid. , 2014, Journal of the American Academy of Dermatology.

[9]  G. Zambruno,et al.  Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  D. Murrell,et al.  A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. , 2013, Journal of the American Academy of Dermatology.

[11]  D. Keene,et al.  De Novo Anti-Type VII Collagen Antibodies in Patients With Recessive Dystrophic Epidermolysis Bullosa , 2013, The Journal of investigative dermatology.

[12]  D. Bonamonte,et al.  Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa , 2013, Orphanet Journal of Rare Diseases.

[13]  R. Ludwig.  Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita , 2013, ISRN dermatology.

[14]  J. Meijer,et al.  The n‐ vs. u‐serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis , 2013, The British journal of dermatology.

[15]  M. Jonkman,et al.  Low sensitivity of type VII collagen enzyme‐linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis , 2013, The British journal of dermatology.

[16]  H. Koga,et al.  Fluorescence overlay antigen mapping using laser scanning confocal microscopy differentiates linear IgA bullous dermatosis from epidermolysis bullosa acquisita mediated by IgA , 2013, The British journal of dermatology.

[17]  D. Zillikens,et al.  Pemphigoid diseases , 2013, The Lancet.

[18]  D. Zillikens,et al.  Serum levels of anti‐type VII collagen antibodies detected by enzyme‐linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  A. Parodi,et al.  Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti‐type VII collagen autoantibodies: an Italian multicentre study , 2013, The British journal of dermatology.

[20]  H. Williams,et al.  Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting , 2012, Allergy.

[21]  D. Zillikens,et al.  Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. , 2012, Journal of the American Academy of Dermatology.

[22]  H. Shimizu,et al.  Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. , 2012, Journal of the American Academy of Dermatology.

[23]  M. Hertl,et al.  Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin‐332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients , 2011, The British journal of dermatology.

[24]  M. Jonkman,et al.  The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy , 2011, The British journal of dermatology.

[25]  Y. Shirakata,et al.  Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. , 2011, Journal of dermatological science.

[26]  Soo-Chan Kim,et al.  Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. , 2011, Acta dermato-venereologica.

[27]  C. Bodemer,et al.  Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa , 2010, Gene Therapy.

[28]  A. Troxel,et al.  Reliability and convergent validity of two outcome instruments for pemphigus. , 2009, The Journal of investigative dermatology.

[29]  H. Shimizu,et al.  Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. , 2008, Journal of the American Academy of Dermatology.

[30]  F. Wojnarowska,et al.  Dermal‐binding linear IgA disease: an uncommon subset of a rare immunobullous disease , 2007, Clinical and experimental dermatology.

[31]  T. Hashimoto,et al.  Case of concurrent epidermolysis bullosa acquisita and anti‐p200 pemphigoid – how to treat it? , 2007, International journal of dermatology.

[32]  A. Dupuy,et al.  A Prospective Study of Upper Aerodigestive Tract Manifestations of Mucous Membrane Pemphigoid , 2006, Medicine.

[33]  M. Ohtsuki,et al.  A Case of Epidermolysis Bullosa Acquisita with Autoantibody to Anti-p200 Pemphigoid Antigen and Exfoliative Esophagitis , 2006, Dermatology.

[34]  Michelle A. Pipitone,et al.  Immunobullous diseases. , 2005, Journal of the American Academy of Dermatology.

[35]  Koichiro Nakamura,et al.  A Case of Anti-p200 Pemphigoid with Autoantibodies against both a Novel 200-kD Dermal Antigen and the 290-kD Epidermolysis bullosa acquisita Antigen , 2004, Dermatology.

[36]  Mei Chen,et al.  A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading. , 2004, Journal of the American Academy of Dermatology.

[37]  C. Kowalewski,et al.  A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy. , 2003, Archives of dermatology.

[38]  R. Vodegel,et al.  IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. , 2002, Journal of the American Academy of Dermatology.

[39]  L. Diaz,et al.  IgM-mediated epidermolysis bullosa acquisita. , 2002, Archives of dermatology.

[40]  D. Kelleher,et al.  The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen. , 2002, The Journal of investigative dermatology.

[41]  K. Yancey,et al.  Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. , 2000, Archives of dermatology.

[42]  Eady,et al.  Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy , 1999, The British journal of dermatology.

[43]  B. Solomon,et al.  Mucosal morbidity in patients with epidermolysis bullosa acquisita. , 1999, Archives of dermatology.

[44]  L. Vaillant,et al.  Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. , 1998, Archives of dermatology.

[45]  M. Kiss,et al.  The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. , 1998, European journal of dermatology : EJD.

[46]  G. Choi,et al.  Epidermolysis Bullosa Acquisita Localized to the Face , 1998, The Journal of dermatology.

[47]  H. Shimizu,et al.  A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[48]  T. Hashimoto,et al.  Epidermolysis bullosa acquisita associated with epidermal‐binding circulating antibodies , 1997, The British journal of dermatology.

[49]  F. Otsuka,et al.  Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant , 1996, The British journal of dermatology.

[50]  K. Yancey,et al.  Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. , 1996, Journal of the American Academy of Dermatology.

[51]  M. Lémann,et al.  Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn's disease. , 1996, The American journal of gastroenterology.

[52]  D. Boorsma,et al.  Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. , 1996, Archives of dermatology.

[53]  C. W. Lee,et al.  Epidermolysis bullosa acquisita presenting with localized facial blisters , 1992, Clinical and experimental dermatology.

[54]  K. Yancey,et al.  Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin. , 1991, Journal of the American Academy of Dermatology.

[55]  W. Stolz,et al.  Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. , 1991, Archives of dermatology.

[56]  E. Beutner,et al.  Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. , 1990, Journal of the American Academy of Dermatology.

[57]  K. Holubar,et al.  Epidermolysis bullosa acquisita. , 1988, The American Journal of dermatopathology.

[58]  D. Woodley,et al.  Review and update of epidermolysis bullosa acquisita. , 1988, Seminars in dermatology.

[59]  R. Burgeson,et al.  Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. , 1988, The Journal of clinical investigation.

[60]  B. Bhogal,et al.  Localization of bullous pemphigoid antibody—an indirect immunofluorescence study of 228 cases using a split‐skin technique , 1987, The British journal of dermatology.

[61]  D. Woodley,et al.  Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). , 1985, The Journal of investigative dermatology.

[62]  D. Woodley,et al.  Epidermolysis bullosa acquisita--a pemphigoid-like disease. , 1984, Journal of the American Academy of Dermatology.

[63]  D. Woodley,et al.  Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. , 1984, The New England journal of medicine.

[64]  A. Inman,et al.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. , 1984, The Journal of investigative dermatology.

[65]  C. Camisa,et al.  Vesiculobullous systemic lupus erythematosus , 1983 .

[66]  R. Briggaman,et al.  Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. , 1982, Journal of the American Academy of Dermatology.

[67]  R. Briggaman,et al.  Epidermolysis bullosa acquisita: ultrastructural and immunological studies. , 1981, The Journal of investigative dermatology.

[68]  D. Boorsma,et al.  Epidermolysis bullosa acquisita , 1980 .

[69]  M. Dahl.  EPIDERMOLYSIS BULLOSA ACQUISITA‐A SIGN OF CICATRICIAL PEMPHIGOID? , 1979, The British journal of dermatology.

[70]  H. Minus,et al.  Epidermolysis bullosa acquisita with electron microscopical studies. , 1975, Archives of dermatology.

[71]  W. Kushniruk.  The immunopathology of epidermolysis bullosa acquisita. , 1973, Canadian Medical Association journal.

[72]  E G Little,et al.  Case of Epidermolysis Bullosa , 1920, Proceedings of the Royal Society of Medicine.

[73]  AgnesF. Savill.  TWO CASES OF EPIDERMOLYSIS BULLOSA. , 1906 .

[74]  E. Sprecher,et al.  Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. , 2015, Journal of the American Academy of Dermatology.

[75]  R. Tellier,et al.  Electron Microscopy and Immunoelectron Microscopy , 2009 .

[76]  R. Vodegel,et al.  Clinical and Laboratory Investigations U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases , 2004 .

[77]  P. Mummaneni,et al.  Report of two cases and review of the literature , 2004 .

[78]  F. Tron,et al.  Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa? , 1993, Journal of the American Academy of Dermatology.

[79]  C. Camisa,et al.  Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature. , 1983, Journal of the American Academy of Dermatology.

[80]  D. Boorsma,et al.  Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. , 1980, The British journal of dermatology.

[81]  H. Roenigk,et al.  Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. , 1971, Archives of dermatology.